GOLM1: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: HTTP→HTTPS)
(removed no longer needed PBB controls and templates consistent citation formatting; removed further reading citations not specific to this gene)
Line 1: Line 1:
{{Infobox_gene}}
{{Infobox_gene}}
'''Golgi membrane protein 1''' (GOLM1) also known as '''Golgi phosphoprotein 2''' or '''Golgi membrane protein GP73''' is a [[protein]] that in humans is encoded by the ''GOLM1'' [[gene]].<ref name="pmid10831838">{{cite journal |vauthors=Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ | title = GP73, a novel Golgi-localized protein upregulated by viral infection | journal = Gene | volume = 249 | issue = 1-2 | pages = 53–65 |date=Jul 2000 | pmid = 10831838 | pmc =  | doi =10.1016/S0378-1119(00)00136-0 }}</ref><ref name="pmid18953438">{{cite journal |vauthors=Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu J, Gu W, Shen R, Ghosh D, Wright LM, Kladney RD, Kuefer R, Rubin MA, Fimmel CJ, Chinnaiyan AM | title = Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer | journal = Neoplasia | volume = 10 | issue = 11 | pages = 1285–94 |date=Oct 2008 | pmid = 18953438 | pmc = 2570605 | doi = }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: GOLPH2 golgi phosphoprotein 2| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51280| accessdate = }}</ref>  Two alternatively spliced transcript variants encoding the same protein have been described for this gene.
'''Golgi membrane protein 1''' (GOLM1) also known as '''Golgi phosphoprotein 2''' or '''Golgi membrane protein GP73''' is a [[protein]] that in humans is encoded by the ''GOLM1'' [[gene]].<ref name="pmid10831838">{{cite journal | vauthors = Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ | title = GP73, a novel Golgi-localized protein upregulated by viral infection | journal = Gene | volume = 249 | issue = 1-2 | pages = 53–65 | date = May 2000 | pmid = 10831838 | pmc =  | doi = 10.1016/S0378-1119(00)00136-0 }}</ref><ref name="pmid18953438">{{cite journal | vauthors = Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu J, Gu W, Shen R, Ghosh D, Wright LM, Kladney RD, Kuefer R, Rubin MA, Fimmel CJ, Chinnaiyan AM | title = Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer | journal = Neoplasia | volume = 10 | issue = 11 | pages = 1285–94 | date = November 2008 | pmid = 18953438 | pmc = 2570605 | doi = 10.1593/neo.08922 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: GOLPH2 golgi phosphoprotein 2| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51280| access-date = }}</ref>  Two alternatively spliced transcript variants encoding the same protein have been described for this gene.


== Function ==
== Function ==
Line 8: Line 8:
== Clinical significance ==
== Clinical significance ==


Golgi membrane protein 1 is overexpressed in [[prostate cancer]]<ref name="pmid18245462">{{cite journal |vauthors=Laxman B, Morris DS, Yu J |title=A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer |journal=Cancer Res. |volume=68 |issue=3 |pages=645–9 |date=February 2008 |pmid=18245462 |pmc=2998181 |doi=10.1158/0008-5472.CAN-07-3224 |url=http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=18245462|display-authors=etal}}</ref><ref name="pmid18543251">{{cite journal |author=Wei, S. |author2=Dunn, T. A. |title=GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus |journal=The Prostate |volume=68 |pages=1387–1395 |year=2008 |pmid=18543251 |doi=10.1002/pros.20806 |url=http://doi.wiley.com/10.1002/pros.20806.|display-authors=etal}}</ref> and lung adenocarcinoma tissue.<ref name="pmid20501332">{{cite journal |vauthors=Zhang F, Gu Y, Li X, Wang W, He J, Peng T |title=Up-regulated Golgi phosphoprotein 2 (GOLPH2)expression in lung adenocarcinoma tissue. |journal=Clinical Biochemistry |volume=43 |issue= 12 |pages= 983–991 |year= 2010 |pmid= 20501332 |doi= 10.1016/j.clinbiochem.2010.05.010 }}</ref>
Golgi membrane protein 1 is overexpressed in [[prostate cancer]]<ref name="pmid18245462">{{cite journal | vauthors = Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM | title = A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer | journal = Cancer Research | volume = 68 | issue = 3 | pages = 645–9 | date = February 2008 | pmid = 18245462 | pmc = 2998181 | doi = 10.1158/0008-5472.CAN-07-3224 | url = http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=18245462 }}</ref><ref name="pmid18543251">{{cite journal | vauthors = Wei S, Dunn TA, Isaacs WB, De Marzo AM, Luo J | title = GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus | journal = The Prostate | volume = 68 | issue = 13 | pages = 1387–95 | date = September 2008 | pmid = 18543251 | pmc = 4124602 | doi = 10.1002/pros.20806 | url = http://doi.wiley.com/10.1002/pros.20806. }}</ref> and lung adenocarcinoma tissue.<ref name="pmid20501332">{{cite journal | vauthors = Zhang F, Gu Y, Li X, Wang W, He J, Peng T | title = Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue | journal = Clinical Biochemistry | volume = 43 | issue = 12 | pages = 983–91 | date = August 2010 | pmid = 20501332 | doi = 10.1016/j.clinbiochem.2010.05.010 }}</ref>


Blood levels of GP73 are higher in patients with liver cancer than in healthy individuals. In addition, levels were not significantly higher in patients with diseases other than liver disease. The current blood test used to screen for early tumors in people at high risk for liver cancer involves the [[alpha-fetoprotein]] (AFP). Patients who are at risk for non-metastatic, or primary, liver cancer typically have chronic liver disease such as [[cirrhosis]]. Such cases of cirrhosis are usually due to infection caused by infectious hepatitis (usually [[hepatitis B]] or [[hepatitis C]], though there are other strains), or because of degenerative [[non-alcoholic fatty liver disease|fatty liver disease]] (which can be especially severe in those with alcoholism). However, the AFP test is not usually sensitive enough to detect liver cancer in time and it often generates false positives. So far, the blood samples of more than 1,000 patients with various stages of liver and non-liver disease have been tested for the presence of GP73 in several studies. Several medical diagnostic companies are in the process of developing automated serum tests for the protein that could be performed in routine hospital laboratories.<ref name="urlLoyola Medicine News Release">{{cite web | url = http://www.loyolamedicine.org/News/News_Releases/news_release_detail.cfm?var_news_release_id=973441154 | title =  New biomarker could lead to the world's first reliable test for liver cancer | date =  2010-04-08 | work = Loyola Medicine News Release | publisher = Loyola University Medical Center | pages = | archiveurl = | archivedate = | accessdate = 2011-05-07 }}</ref>
Blood levels of GP73 are higher in patients with liver cancer than in healthy individuals. In addition, levels were not significantly higher in patients with diseases other than liver disease. The current blood test used to screen for early tumors in people at high risk for liver cancer involves the [[alpha-fetoprotein]] (AFP). Patients who are at risk for non-metastatic, or primary, liver cancer typically have chronic liver disease such as [[cirrhosis]]. Such cases of cirrhosis are usually due to infection caused by infectious hepatitis (usually [[hepatitis B]] or [[hepatitis C]], though there are other strains), or because of degenerative [[non-alcoholic fatty liver disease|fatty liver disease]] (which can be especially severe in those with alcoholism). However, the AFP test is not usually sensitive enough to detect liver cancer in time and it often generates false positives. So far, the blood samples of more than 1,000 patients with various stages of liver and non-liver disease have been tested for the presence of GP73 in several studies. Several medical diagnostic companies are in the process of developing automated serum tests for the protein that could be performed in routine hospital laboratories.<ref name="urlLoyola Medicine News Release">{{cite web | url = http://www.loyolamedicine.org/News/News_Releases/news_release_detail.cfm?var_news_release_id=973441154 | title =  New biomarker could lead to the world's first reliable test for liver cancer | date =  2010-04-08 | work = Loyola Medicine News Release | publisher = Loyola University Medical Center | pages = | archive-url = | archive-date = | access-date = 2011-05-07 }}</ref>


==References==
== References ==
{{reflist}}
{{reflist}}


==Further reading==
== Further reading ==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading
* {{cite journal | vauthors = Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ | title = Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease | journal = Hepatology | volume = 35 | issue = 6 | pages = 1431–40 | date = June 2002 | pmid = 12029628 | doi = 10.1053/jhep.2002.32525 }}
| citations =
* {{cite journal | vauthors = Bauer K, Zemlin M, Hummel M, Pfeiffer S, Karstaedt J, Steinhauser G, Xiao X, Versmold H, Berek C | title = Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens | journal = Journal of Immunology | volume = 169 | issue = 3 | pages = 1349–56 | date = August 2002 | pmid = 12133958 | doi = 10.4049/jimmunol.169.3.1349 }}
*{{cite journal |vauthors=Kladney RD, Cui X, Bulla GA |title=Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. |journal=Hepatology |volume=35 |issue= 6 |pages= 1431–40 |year= 2002 |pmid= 12029628 |doi= 10.1053/jhep.2002.32525 |display-authors=etal}}
* {{cite journal | vauthors = Puri S, Bachert C, Fimmel CJ, Linstedt AD | title = Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption | journal = Traffic | volume = 3 | issue = 9 | pages = 641–53 | date = September 2002 | pmid = 12191016 | doi = 10.1034/j.1600-0854.2002.30906.x }}
*{{cite journal |vauthors=Bauer K, Zemlin M, Hummel M |title=Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens. |journal=J. Immunol. |volume=169 |issue= 3 |pages= 1349–56 |year= 2002 |pmid= 12133958 |doi= 10.4049/jimmunol.169.3.1349|display-authors=etal}}
* {{cite journal | vauthors = Kladney RD, Tollefson AE, Wold WS, Fimmel CJ | title = Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain | journal = Virology | volume = 301 | issue = 2 | pages = 236–46 | date = September 2002 | pmid = 12359426 | doi = 10.1006/viro.2002.1523 }}
*{{cite journal |vauthors=Puri S, Bachert C, Fimmel CJ, Linstedt AD |title=Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. |journal=Traffic |volume=3 |issue= 9 |pages= 641–53 |year= 2003 |pmid= 12191016 |doi=10.1034/j.1600-0854.2002.30906.x }}
* {{cite journal | vauthors = Zhang H, Li XJ, Martin DB, Aebersold R | title = Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry | journal = Nature Biotechnology | volume = 21 | issue = 6 | pages = 660–6 | date = June 2003 | pmid = 12754519 | doi = 10.1038/nbt827 }}
*{{cite journal |vauthors=Kladney RD, Tollefson AE, Wold WS, Fimmel CJ |title=Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. |journal=Virology |volume=301 |issue= 2 |pages= 236–46 |year= 2002 |pmid= 12359426 |doi=10.1006/viro.2002.1523 }}
* {{cite journal | vauthors = Otsuki T, Ota T, Nishikawa T, Hayashi K, Suzuki Y, Yamamoto J, Wakamatsu A, Kimura K, Sakamoto K, Hatano N, Kawai Y, Ishii S, Saito K, Kojima S, Sugiyama T, Ono T, Okano K, Yoshikawa Y, Aotsuka S, Sasaki N, Hattori A, Okumura K, Nagai K, Sugano S, Isogai T | title = Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries | journal = DNA Research | volume = 12 | issue = 2 | pages = 117–26 | year = 2007 | pmid = 16303743 | doi = 10.1093/dnares/12.2.117 }}
*{{cite journal  |vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899  | pmc=139241 |display-authors=etal}}
* {{cite journal | vauthors = Ramachandran P, Boontheung P, Xie Y, Sondej M, Wong DT, Loo JA | title = Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry | journal = Journal of Proteome Research | volume = 5 | issue = 6 | pages = 1493–503 | date = June 2006 | pmid = 16740002 | doi = 10.1021/pr050492k }}
*{{cite journal |vauthors=Zhang H, Li XJ, Martin DB, Aebersold R |title=Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. |journal=Nat. Biotechnol. |volume=21 |issue= 6 |pages= 660–6 |year= 2003 |pmid= 12754519 |doi= 10.1038/nbt827 }}
* {{cite journal | vauthors = Bachert C, Fimmel C, Linstedt AD | title = Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma | journal = Traffic | volume = 8 | issue = 10 | pages = 1415–23 | date = October 2007 | pmid = 17662025 | doi = 10.1111/j.1600-0854.2007.00621.x }}
*{{cite journal |vauthors=Clark HF, Gurney AL, Abaya E |title=The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. |journal=Genome Res. |volume=13 |issue= 10 |pages= 2265–70 |year= 2003 |pmid= 12975309 |doi= 10.1101/gr.1293003  | pmc=403697 |display-authors=etal}}
* {{cite journal | vauthors = Gu Y, Chen W, Zhao Y, Chen L, Peng T | title = Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases | journal = Annals of Clinical Biochemistry | volume = 46 | issue = Pt 1 | pages = 38–43 | date = January 2009 | pmid = 19008260 | doi = 10.1258/acb.2008.008088 }}
*{{cite journal  |vauthors=Ota T, Suzuki Y, Nishikawa T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs. |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |display-authors=etal}}
* {{cite journal | vauthors = Zhou Y, Li L, Hu L, Peng T | title = Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin | journal = Molecular Biology Reports | volume = 38 | issue = 3 | pages = 1457–62 | date = March 2011 | pmid = 20842452 | doi = 10.1007/s11033-010-0251-7 }}
*{{cite journal  |vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504  | pmc=528928 |display-authors=etal}}
*{{cite journal  |vauthors=Stelzl U, Worm U, Lalowski M |title=A human protein-protein interaction network: a resource for annotating the proteome. |journal=Cell |volume=122 |issue= 6 |pages= 957–68 |year= 2005 |pmid= 16169070 |doi= 10.1016/j.cell.2005.08.029 |display-authors=etal}}
*{{cite journal  |vauthors=Otsuki T, Ota T, Nishikawa T |title=Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries. |journal=DNA Res. |volume=12 |issue= 2 |pages= 117–26 |year= 2007 |pmid= 16303743 |doi= 10.1093/dnares/12.2.117 |display-authors=etal}}
*{{cite journal |vauthors=Liu T, Qian WJ, Gritsenko MA |title=Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. |journal=J. Proteome Res. |volume=4 |issue= 6 |pages= 2070–80 |year= 2006 |pmid= 16335952 |doi= 10.1021/pr0502065  | pmc=1850943 |display-authors=etal}}
*{{cite journal  |vauthors=Ramachandran P, Boontheung P, Xie Y |title=Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. |journal=J. Proteome Res. |volume=5 |issue= 6 |pages= 1493–503 |year= 2006 |pmid= 16740002 |doi= 10.1021/pr050492k |display-authors=etal}}
*{{cite journal |vauthors=Bachert C, Fimmel C, Linstedt AD |title=Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. |journal=Traffic |volume=8 |issue= 10 |pages= 1415–23 |year= 2007 |pmid= 17662025 |doi= 10.1111/j.1600-0854.2007.00621.x }}
*{{cite journal | doi=10.1258/acb.2008.008088  |vauthors=Gu Y, Chen W, Zhao Y, Chen L, Peng T |title=Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases. |journal=Ann. Clin. Biochem. |volume=46 |issue= 1 |pages= 38–43 |year= 2009 |pmid= 19008260 }}
*{{cite journal |vauthors=Zhou Y, Li L, Hu L, Peng T |title=Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin. |journal=Mol Biol Rep.  | volume=38 | issue=3 | pages=1457–1462 |year= 2010 |pmid= 20842452 |doi= 10.1007/s11033-010-0251-7 }}
}}
{{refend}}
{{refend}}


<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}
{{Tumor markers}}
{{Tumor markers}}


{{gene-9-stub}}
{{gene-9-stub}}

Revision as of 21:35, 11 May 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Golgi membrane protein 1 (GOLM1) also known as Golgi phosphoprotein 2 or Golgi membrane protein GP73 is a protein that in humans is encoded by the GOLM1 gene.[1][2][3] Two alternatively spliced transcript variants encoding the same protein have been described for this gene.

Function

The Golgi complex plays a key role in the sorting and modification of proteins exported from the endoplasmic reticulum. The protein encoded by this gene is a type II Golgi transmembrane protein. It processes protein synthesized in the rough endoplasmic reticulum and assists in the transport of protein cargo through the Golgi apparatus. The expression of this encoded protein has been observed to be upregulated in response to viral infection.[3]

Clinical significance

Golgi membrane protein 1 is overexpressed in prostate cancer[4][5] and lung adenocarcinoma tissue.[6]

Blood levels of GP73 are higher in patients with liver cancer than in healthy individuals. In addition, levels were not significantly higher in patients with diseases other than liver disease. The current blood test used to screen for early tumors in people at high risk for liver cancer involves the alpha-fetoprotein (AFP). Patients who are at risk for non-metastatic, or primary, liver cancer typically have chronic liver disease such as cirrhosis. Such cases of cirrhosis are usually due to infection caused by infectious hepatitis (usually hepatitis B or hepatitis C, though there are other strains), or because of degenerative fatty liver disease (which can be especially severe in those with alcoholism). However, the AFP test is not usually sensitive enough to detect liver cancer in time and it often generates false positives. So far, the blood samples of more than 1,000 patients with various stages of liver and non-liver disease have been tested for the presence of GP73 in several studies. Several medical diagnostic companies are in the process of developing automated serum tests for the protein that could be performed in routine hospital laboratories.[7]

References

  1. ↑ Kladney RD, Bulla GA, Guo L, Mason AL, Tollefson AE, Simon DJ, Koutoubi Z, Fimmel CJ (May 2000). "GP73, a novel Golgi-localized protein upregulated by viral infection". Gene. 249 (1–2): 53–65. doi:10.1016/S0378-1119(00)00136-0. PMID 10831838.
  2. ↑ Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA, Granger J, Vellaichamy A, Sreekumar A, Yu J, Gu W, Shen R, Ghosh D, Wright LM, Kladney RD, Kuefer R, Rubin MA, Fimmel CJ, Chinnaiyan AM (November 2008). "Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer". Neoplasia. 10 (11): 1285–94. doi:10.1593/neo.08922. PMC 2570605. PMID 18953438.
  3. ↑ 3.0 3.1 "Entrez Gene: GOLPH2 golgi phosphoprotein 2".
  4. ↑ Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R, Lonigro RJ, Tsodikov A, Wei JT, Tomlins SA, Chinnaiyan AM (February 2008). "A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer". Cancer Research. 68 (3): 645–9. doi:10.1158/0008-5472.CAN-07-3224. PMC 2998181. PMID 18245462.
  5. ↑ Wei S, Dunn TA, Isaacs WB, De Marzo AM, Luo J (September 2008). "GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus". The Prostate. 68 (13): 1387–95. doi:10.1002/pros.20806. PMC 4124602. PMID 18543251.
  6. ↑ Zhang F, Gu Y, Li X, Wang W, He J, Peng T (August 2010). "Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue". Clinical Biochemistry. 43 (12): 983–91. doi:10.1016/j.clinbiochem.2010.05.010. PMID 20501332.
  7. ↑ "New biomarker could lead to the world's first reliable test for liver cancer". Loyola Medicine News Release. Loyola University Medical Center. 2010-04-08. Retrieved 2011-05-07.

Further reading

  • Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ (June 2002). "Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease". Hepatology. 35 (6): 1431–40. doi:10.1053/jhep.2002.32525. PMID 12029628.
  • Bauer K, Zemlin M, Hummel M, Pfeiffer S, Karstaedt J, Steinhauser G, Xiao X, Versmold H, Berek C (August 2002). "Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens". Journal of Immunology. 169 (3): 1349–56. doi:10.4049/jimmunol.169.3.1349. PMID 12133958.
  • Puri S, Bachert C, Fimmel CJ, Linstedt AD (September 2002). "Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption". Traffic. 3 (9): 641–53. doi:10.1034/j.1600-0854.2002.30906.x. PMID 12191016.
  • Kladney RD, Tollefson AE, Wold WS, Fimmel CJ (September 2002). "Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain". Virology. 301 (2): 236–46. doi:10.1006/viro.2002.1523. PMID 12359426.
  • Zhang H, Li XJ, Martin DB, Aebersold R (June 2003). "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry". Nature Biotechnology. 21 (6): 660–6. doi:10.1038/nbt827. PMID 12754519.
  • Otsuki T, Ota T, Nishikawa T, Hayashi K, Suzuki Y, Yamamoto J, Wakamatsu A, Kimura K, Sakamoto K, Hatano N, Kawai Y, Ishii S, Saito K, Kojima S, Sugiyama T, Ono T, Okano K, Yoshikawa Y, Aotsuka S, Sasaki N, Hattori A, Okumura K, Nagai K, Sugano S, Isogai T (2007). "Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries". DNA Research. 12 (2): 117–26. doi:10.1093/dnares/12.2.117. PMID 16303743.
  • Ramachandran P, Boontheung P, Xie Y, Sondej M, Wong DT, Loo JA (June 2006). "Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry". Journal of Proteome Research. 5 (6): 1493–503. doi:10.1021/pr050492k. PMID 16740002.
  • Bachert C, Fimmel C, Linstedt AD (October 2007). "Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma". Traffic. 8 (10): 1415–23. doi:10.1111/j.1600-0854.2007.00621.x. PMID 17662025.
  • Gu Y, Chen W, Zhao Y, Chen L, Peng T (January 2009). "Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases". Annals of Clinical Biochemistry. 46 (Pt 1): 38–43. doi:10.1258/acb.2008.008088. PMID 19008260.
  • Zhou Y, Li L, Hu L, Peng T (March 2011). "Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin". Molecular Biology Reports. 38 (3): 1457–62. doi:10.1007/s11033-010-0251-7. PMID 20842452.
Retrieved from "https://www.wikidoc.org/index.php?title=GOLM1&oldid=1522904"